Pre-trained MRI-based Alzheimer's disease classification models to classify memory clinic patients

Artificial intelligence for diagnostic and prognostic neuroimaging in dementia: A systematic review

INTRODUCTION

Artificial intelligence (AI) and neuroimaging offer new opportunities for diagnosis and prognosis of dementia.

METHODS

We systematically reviewed studies reporting AI for neuroimaging in diagnosis and/or prognosis of cognitive neurodegenerative diseases.

RESULTS

A total of 255 studies were identified. Most studies relied on the Alzheimer's Disease Neuroimaging Initiative dataset. Algorithmic classifiers were the most commonly used AI method (48%) and discriminative models performed best for differentiating Alzheimer's disease from controls. The accuracy of algorithms varied with the patient cohort, imaging modalities, and stratifiers used. Few studies performed validation in an independent cohort.

DISCUSSION

The literature has several methodological limitations including lack of sufficient algorithm development descriptions and standard definitions. We make recommendations to improve model validation including addressing key clinical questions, providing sufficient description of AI methods and validating findings in independent datasets. Collaborative approaches between experts in AI and medicine will help achieve the promising potential of AI tools in practice.

HIGHLIGHTS

There has been a rapid expansion in the use of machine learning for diagnosis and prognosis in neurodegenerative disease Most studies (71%) relied on the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset with no other individual dataset used more than five times There has been a recent rise in the use of more complex discriminative models (e.g., neural networks) that performed better than other classifiers for classification of AD vs healthy controls We make recommendations to address methodological considerations, addressing key clinical questions, and validation We also make recommendations for the field more broadly to standardize outcome measures, address gaps in the literature, and monitor sources of bias.

Deep Learning-Based Ensembling Technique to Classify Alzheimer's Disease Stages Using Functional MRI

The major issue faced by elderly people in society is the loss of memory, difficulty learning new things, and poor judgment. This is due to damage to brain tissues, which may lead to cognitive impairment and eventually Alzheimer's. Therefore, the detection of such mild cognitive impairment (MCI) becomes important. Usually, this is detected when it is converted into Alzheimer's disease (AD). AD is irreversible and cannot be cured whereas mild cognitive impairment (MCI) can be cured. The goal of this research is to diagnose Alzheimer's patients for timely treatment. For this purpose, functional MRI images from the publicly available dataset are used. Various deep-learning models have been used by the scientific community for the automatic detection of Alzheimer's subjects. These include the binary classification of scans of patients into MCI and AD stages, and limited work is carried out for multiclass classification of Alzheimer's disease up to six different stages. This study is divided into two steps. In the first step, a binary classification of the subject's scan is performed using Custom CNN. The second step involves the use of different deep learning models along with Custom CNN for multiclass classification of a subject's scan into one of the six stages of Alzheimer's disease. The models are evaluated based on different evaluation metrics, and the overall result of the models is improved using the max-voting ensembling technique. The experimental results show that an overall average accuracy of 98.8% is achieved for Alzheimer's stages classification.